Correlation Between Regencell Bioscience and Shuttle Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regencell Bioscience Holdings and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Regencell Bioscience and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Shuttle Pharmaceuticals.

Diversification Opportunities for Regencell Bioscience and Shuttle Pharmaceuticals

0.53

Correlation Coefficient

Regencell Bioscience  Shuttle Pharmaceuticals

Very weak diversification

The 3 months correlation between Regencell and Shuttle is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Shuttle Pharmaceuticals

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to under-perform the Shuttle Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Regencell Bioscience Holdings is 1.48 times less risky than Shuttle Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The Shuttle Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  78.00  in Shuttle Pharmaceuticals on October 10, 2024 and sell it today you would earn a total of  9.00  from holding Shuttle Pharmaceuticals or generate 11.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Regencell Bioscience Holdings  vs.  Shuttle Pharmaceuticals

Regencell Bioscience

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Shuttle Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Regencell Bioscience and Shuttle Pharmaceuticals

The main advantage of trading using opposite Regencell Bioscience and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.

The idea behind Regencell Bioscience Holdings and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.